Expanding Options for Relapsed/Refractory Gastrointestinal Stromal Tumors
EP. 1: Challenges Associated with GIST Management
By
Targeted Oncology
July 1st 2020
EP. 2: Mutations in Gastrointestinal Stromal Tumors
By
Targeted Oncology
July 1st 2020
EP. 3: GIST Mutations: Are Some Worse Than Others?
By
Targeted Oncology
July 1st 2020
EP. 4: GIST Mutations: Treatment Decision Factors
By
Targeted Oncology
July 1st 2020
EP. 5: Standard Treatment Options for Metastatic GIST
By
Targeted Oncology
July 1st 2020
EP. 6: Unmet Needs in GIST: Toxicity Management
By
Targeted Oncology
July 1st 2020
EP. 7: Treatment Options After Relapse
By
Targeted Oncology
July 1st 2020
EP. 8: Recently Approved Targeted Therapy for Fourth-Line GIST
By
Targeted Oncology
July 1st 2020
EP. 9: INTRIGUE Trial Overview
By
Targeted Oncology
July 1st 2020
EP. 10: NAVIGATOR Trial Overview
By
Targeted Oncology
July 1st 2020
EP. 11: Advanced GIST: The Impact of Newly Approved Agents
By
Targeted Oncology
July 1st 2020
